← Back
$CRSP All transactions

CRISPR Therapeutics AG

A

$ Value

$0

Shares

38,499

Price

$0

Filed

Mar 24

Insider

Name

Patel Naimish

Title

Chief Medical Officer

CIK

0002021679

Roles

Officer

Transaction Details

Transaction Date

2026-03-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,499

Footnotes

These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. | This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026. | Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. | This restricted stock unit award was granted on March 20, 2026 with respect to 30,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030.

Filing Info

Accession No.

0001193125-26-122267

Form Type

4

Issuer CIK

0001674416

Patel Naimish's History

Date Ticker Type Value
2026-03-20 CRSP A $0
2026-03-20 CRSP A $0
2025-10-03 CRSP A $0
2025-05-30 CRSP A $0
2025-05-29 CRSP $141K
2025-05-28 CRSP M
2025-05-28 CRSP M

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20